#BioTech

BioMedNewsBreaks - $ADPT.CN Sees Regulatory Landscape Shift as Federal Policy Permits Compounding of Six Peptides, Reuters Reports #stocks #biotech #pharmaceutical #healthnews

🧬 Biotech VC weekly roundup: Oncology, regeneration and genomics. We round up the investments you should know about → #Biotech #VC

1/ For the first time, some hepatitis B patients may be able to STOP their daily medicine — and stay in control. The FDA just approved Hibsago. 🧵

5/ “Functional cure” means the virus's DNA undetectable and its surface antigen gone for at least 24 weeks after stopping ALL hepatitis B treatment. It's for certain adults without cirrhosis, after a 6-month course.

6/ 19% is a breakthrough, not a guarantee. Would you take a 6-month course for a roughly 1-in-5 shot at stopping daily pills for good? #Biotech #HepatitisB #FDA

We have barely scratched the surface of what is possible with peptides. With over 10 to the 65th potential combinations and AI now screening trillions of molecules, we are entering a new frontier in medicine. The future of drug discovery is here. #Biotech #Innovation

We have barely scratched the surface of what is possible with peptides. With over 10 to the 65th potential combinations and AI now screening trillions of molecules, we are entering a new frontier in medicine. The future of drug discovery is here. #Biotech #Innovation

New Biotech Data Centers Use Lab-Grown Human Neurons & "Close your Eyes We'll Immunize" dlvr.​it/TW2Wzc #Biotech #Neuroscience #DataCenters

BioNTech seeks a breakthrough with its cancer pipeline, DroneShield battles short sellers and Cardiol Therapeutics targets a rebound! #biotech #rebound #technical analysis #droneshield #biontech #cardiol #therapeutics #moderna #cancer #pipeline

Report from Global Banking & Finance Review Perspective Therapeutics (CATX) shares fell 24.84% on its US listing, drawing attention to the biotech stock and market debut. Follow CATX stock news, US IPOs and biotech market trends. #PerspectiveTherapeutics #CATX #Biotech #Stocks #IPO

Doctors are calling Moderna and Merck's cancer vaccine data a major advancement despite Wall Street's reaction. Clinical validation is the signal here, and the tape can catch up once investors do a real commercial read. $MRNA #biotech

We have only scratched the surface of human biology. Researchers have identified thousands of small, overlooked peptides in the dark proteome—and AI is now helping us screen trillions of these molecules to unlock the next generation of medicine. #Biotech #Science

There’s virtually no competition for DCVax in the way many investors seem to think. The recent mRNA trial setbacks reinforce the importance of the approach Marnix Bosch discussed back in 2023. #NWBO #DCVax #Biotech #Immunotherapy #CancerResearch

Curious about the secrets of successful biotechs? 🌟 We dive into their origin stories, leadership, pipelines, and investors! Tune into Pharm2Market's Target Space podcast wherever you listen: #Biotech #Podcasts

📊 aKTIV8 Daily Brief — 2026-10-25 Today's Global Life Sciences Landscape Full brief → #biotech #pharma #BD

Scientists Just Revived Pig Kidneys Frozen for a Year. It Could Rewrite the Future of Organ Transplants - Gizmodo #biotech #geneediting #genomeengineering #lifesciences #drugdevelopment #biomedical

DNA synthesis is advancing toward longer, more complex constructs and faster production. The Synthetic Biology Market is set to grow from $26.64B in 2025 to $57.20B by 2030. Free Sample: #SyntheticBiology #DNASynthesis #Biotech #GeneEngineering #tbrc

Wearable-derived phenotypes are starting to challenge how we define disease severity. When continuous sensor data tells a different story than a clinician's six-month assessment, deciding which one to trust is a clinical and regulatory question worth taking seriously. #BioTech

Is Synthetic Biology Worth the Risk? - National Wildlife Federation #biotech #geneediting #genomeengineering #lifesciences #drugdevelopment #biomedical

🤯 Game changer alert! Gene editing just got a whole lot faster, what does this mean for human evolution? #BioTech #FutureIsNow #Science

Which VC firms are investing in biotech companies like mine? 🤔 Discover precise data with Pharm2Market's database! #Biotech #Investing #News #Intelligence Got questions? Pharm2Market's got the answers.

Which San Diego biotechs are tackling cancer? 🌟 Pharm2Market’s Biotech Hub has the latest news, events, and VC trends for founders, sales reps & job seekers! #Biotech #News #Intelligence 🌟 Got questions? Pharm2Market has the answers!